跳至主要内容
临床试验/NL-OMON31584
NL-OMON31584撤回4 期

Influence of methylphenidate on sleep and circadian rhythm in children with Attention-Deficit/Hyperactivity Disorder (ADHD) - MELMET Study

Ziekenhuisvoorzieningen Gelderse Vallei0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • •Age 6-12 years
  • •Recently diagnosed ADHD
  • •Indication for starting with methylphenidate treatment and assignment by the paediatrician to a short methylphenidate/placebo trail.

排除标准

  • •Treatment with stimulants, melatonin, clonidine, risperidon, benzodiazepines
  • •Prior treatment with melatonin (>0.1 mg)
  • •Contraindications for using methylfenidate
  • •Tourette*s syndrome
  • •Anxiety disorder
  • •Pervasive developmental disorder
  • •Severe ADHD symptoms ( serious behavioural-, attention or learning problems heavily interfering with the child*s live ) in which no delay can be made with the initiation of methylphenidate treatment.

研究者

发起方
Ziekenhuisvoorzieningen Gelderse Vallei

相似试验